• Protecting the health and well being of Albertans is a priority of this government.
• Arexvy was approved by Health Canada for use in adults 60 years of age and older on August 4, 2023.
• Alberta Health is awaiting guidance from the National Advisory Committee on Immunization (NACI) prior to making recommendations on the use of Arexvy in Alberta.
• Alberta Health will not be funding Arexvy for the upcoming RSV season.
• Once vaccine supply arrives in Canada this fall, this vaccine will be available for purchase in Alberta, and so individuals in the eligible population (60+) may choose to access Arexvy if it is covered through private health insurance or if they want to pay out-of-pocket.
Respiratory Syncytial Virus Vaccine
• Protecting the health and well being of Albertans is a priority of this government.
• Arexvy was approved by Health Canada for use in adults 60 years of age and older on August 4, 2023.
• Alberta Health is awaiting guidance from the National Advisory Committee on Immunization (NACI) prior to making recommendations on the use of Arexvy in Alberta.
• Alberta Health will not be funding Arexvy for the upcoming RSV season.
• Once vaccine supply arrives in Canada this fall, this vaccine will be available for purchase in Alberta, and so individuals in the eligible population (60+) may choose to access Arexvy if it is covered through private health insurance or if they want to pay out-of-pocket.
Read more here: Respiratory Syncytial Virus (RSV) Vaccine for adults who are 60+ years of age
Search
Recent Posts
Refocusing Health Care in Alberta
January 10, 2025Newsletters
October 2, 2024What is Continuing Care?
February 2, 2024Volunteers Needed
February 2, 2024RSV Vaccine for Adults
October 10, 2023Popular Categories